Andrea Pfeifer

Co-Founder at AC Immune SA

Andrea Pfeifer

Andrea Pfeifer

Co-Founder at AC Immune SA

Overview
Career Highlights

AC Immune SA
Inventages II

RelSci Relationships

795

Number of Boards

7

Birthday

09/1958

Age

61

Number of Awards

2

Contact Data
Trying to get in touch with Andrea Pfeifer? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Andrea Pfeifer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder & Managing Director at dievini Hopp BioTech holding GmbH & Co. KG

Relationship likelihood: Strong

AC Immune SA

Relationship likelihood: Strong

Co-Founder at dievini Hopp BioTech holding GmbH & Co. KG

Relationship likelihood: Strong

Co-Founder at AB2 Bio SA

Relationship likelihood: Strong

Co-Founder, Director at Sumerian Europe Ltd.

Relationship likelihood: Strong

Member, Board of Directors at AC Immune SA

Relationship likelihood: Strong

Former Global Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Vice Chairman at Blaser Bauglas AG

Relationship likelihood: Strong

Member, Board of Directors at BioMedPartners AG

Relationship likelihood: Strong

Chief Financial Officer at Generation Bio Co.

Relationship likelihood: Strong

Paths to Andrea Pfeifer
Potential Connections via
Relationship Science
You
Andrea Pfeifer
Co-Founder at AC Immune SA
Education
Ph.D. in Toxicology, Cancer Research

http://www.uni-wuerzburg.de/ueber/universitaet_wuerzburg/

Habilitation

The University of Lausanne is a higher teaching and research institution composed of seven faculties where approximately 14,300 students and 3,000 researchers work and study. UNIL is focused on several academic disciplines, especially Medicine, Life Sciences, Geosciences, Environment, Business, Humanities and Social Sciences. An emphasis is placed on an interdisciplinary approach, with close cooperation between students, teaching staff, and professors.

Career History
Co-Founder
2003 - Current

AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Professor
Tenure Unconfirmed

The University of Lausanne is a higher teaching and research institution composed of seven faculties where approximately 14,300 students and 3,000 researchers work and study. UNIL is focused on several academic disciplines, especially Medicine, Life Sciences, Geosciences, Environment, Business, Humanities and Social Sciences. An emphasis is placed on an interdisciplinary approach, with close cooperation between students, teaching staff, and professors.

Co-Founder
Prior

Inventages II (Life Ventures) launched by Nestlé and managed by Inventages Ventures Capital GmbH with the objective to provide capital to start-ups at life sciences (food and nutrition in general, health-enhancing food, agricultural biotechnology), as well as commercial applications, such as consumer relation management, food processes and packaging technologies.

Boards & Committees
Chairperson, Board of Directors
Current

BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million.

Member, Supervisory Board
Current

Symrise AG is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. It operates through the following three segments: Scent & Care, Flavor and Nutrition. The Scent and Care segment develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas. The Flavor segment offers flavors and ingredients which are used in beverages, savory and sweet business. The Nutrition segment offers solutions for food production based on natural ingredients. The company was founded in 2003 and is headquartered in Holzminden, Germany.

Investments
Details Hidden

AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2009
World Economic Forum - Technology Pioneer
Registered Pharmacist
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Andrea Pfeifer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Andrea Pfeifer's profile does not indicate a business or promotional relationship of any kind between RelSci and Andrea Pfeifer.